Gov’ t Secures 400,000 Molnupiravir Tablets as Omicron Cases Rise

Health Minister Budi Gunadi Sadikin gos to Amarox Pharma Global manufacturing plant in Cikarang on Jan. 14, 2022.

Jakarta. The Indonesian federal government announced on Wednesday that it had actually secured 400,000 tablets of the Covid-19 antiviral drug Molnupiravir, while likewise reporting that the nation’s overall tally of the Omicron variation had leapt to 882 cases.

Indonesia is teaming up with Amarox Pharma Global, a subsidiary of India’s generic pharmaceutical company Hetero, to produce Molnupiravir.

” The Health Ministry has actually protected 400,000 tablets of Molnupiravir that have actually been prepared by Amarox,” the federal government’s Covid-19 spokesperson Reisa Broto Asmoro told a press conference on Wednesday.

According to Reisa, Amarox is anticipated to begin the domestic production of Molnupiravir in April or May 2022.

” The federal government continues to make sure the domestic supply of Covid-19 medicines to prepare for waves of the SARS-CoV-2 virus. Among others by preparing new antiviral drugs, particularly Molnupiravir and Paxlovid,” she said.

Reisa reported, since Jan. 18, Indonesia had actually detected 882 Omicron infections. About 276 Omicron-infected patients have actually recovered as of Jan.14

National Health Durability


Last week, Health Minister Budi Gunadi Sadikin checked out Amarox’s manufacturing plant in Cikarang.

During the go to, Budi mentioned the need to strengthen national health strength by producing pharmaceutical drugs within the nation Domestic production of vital medications will avoid Indonesia from needing to count on other countries when facing a pandemic, while also creating new task chances.

” We truly support the health system reform efforts in Indonesia. We are prepared to produce important medications for individuals,” Amarox Pharma Global country supervisor Sandeep Sur said in a recent declaration.

He also revealed Amarox’s dedication to assisting Indonesia’s Covid-19 battle. With the local production in Cikarang, Indonesia will not require to import its Covid-19 antiviral drugs, according to Sandeep Sur.